Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guangsheng He
The Third-Time Chronic Myeloid Leukemia in Lymphoblastic Crisis With ABL1 Kinase Mutation Induced by Decitabine, Dexamethason Combined With Nilotinib and Dasatinib
Journal of Translational Internal Medicine
Related publications
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica
Hematology
Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Requirement of SRC Kinases Lyn, HCK and FGR for BCR-ABL1-induced B-Lymphoblastic Leukemia but Not Chronic Myeloid Leukemia
Nature Genetics
Genetics
Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib
Clinical Management Issues
Medicine
Accounting
Management
Business
Imatinib Failure and Response to Dasatinib in a Patient With Chronic Myeloid Leukemia in Blast Crisis and a Novel, Nine-Nucleotide BCR-ABL Insertion Mutation
Blood Cancer Journal
Oncology
Hematology
The Impact of BCR-ABL1 Transcript Type on Tyrosine Kinase Inhibitor Responses and Outcomes in Patients With Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
